HomeCompareGAWK vs MRK

GAWK vs MRK: Dividend Comparison 2026

GAWK yields 3333.33% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GAWK wins by $1244041712890.34M in total portfolio value
10 years
GAWK
GAWK
● Live price
3333.33%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1244041712890.40M
Annual income
$1,174,716,366,071,938,000.00
Full GAWK calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — GAWK vs MRK

📍 GAWK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGAWKMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GAWK + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GAWK pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GAWK
Annual income on $10K today (after 15% tax)
$283,333.33/yr
After 10yr DRIP, annual income (after tax)
$998,508,911,161,147,300.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, GAWK beats the other by $998,508,911,161,138,700.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GAWK + MRK for your $10,000?

GAWK: 50%MRK: 50%
100% MRK50/50100% GAWK
Portfolio after 10yr
$622020856445.23M
Annual income
$587,358,183,035,974,100.00/yr
Blended yield
94.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GAWK
No analyst data
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GAWK buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGAWKMRK
Forward yield3333.33%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1244041712890.40M$57.7K
Annual income after 10y$1,174,716,366,071,938,000.00$10,113.78
Total dividends collected$1239274250481.68M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GAWK vs MRK ($10,000, DRIP)

YearGAWK PortfolioGAWK Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$344,033$333,333.33$11,213$373.04+$332.8KGAWK
2$11,085,665$10,717,549.33$12,667$512.06+$11.07MGAWK
3$334,616,633$322,754,971.08$14,439$708.14+$334.60MGAWK
4$9,462,934,690$9,104,894,892.71$16,640$988.16+$9462.92MGAWK
5$250,766,259,005$240,640,918,887.41$19,432$1,394.07+$250766.24MGAWK
6$6,228,082,462,189$5,959,762,565,053.11$23,057$1,992.90+$6228082.44MGAWK
7$144,998,525,500,125$138,334,477,265,582.72$27,889$2,894.79+$144998525.47MGAWK
8$3,165,074,899,913,431$3,009,926,477,628,297.00$34,518$4,286.29+$3165074899.88MGAWK
9$64,790,043,755,570,470$61,403,413,612,663,110.00$43,912$6,494.35+$64790043755.53MGAWK
10$1,244,041,712,890,398,500$1,174,716,366,071,938,000.00$57,714$10,113.78+$1244041712890.34MGAWK

GAWK vs MRK: Complete Analysis 2026

GAWKStock

Gawk Incorporated provides a suite of cloud communications, cloud connectivity, cloud computing, and managed cloud-based applications solutions to small, medium, and large businesses; and domestic and international voice services to communications carriers worldwide. It offers a suite of advanced data center and cloud-based services, including fault tolerant and high availability cloud servers, which comprise platform as a service, infrastructure as a service, and a content delivery network; managed network services that converge voice and data applications, structured cabling, wireless, and security services, as well as include Internet access via Ethernet or fiber at speeds ranging from 10 Mbps to 10 Gbps; and data center solutions, including cloud services, colocation services, and business continuity services, such as storage and security. The company also provides unified communications services, including device and location agnostic; wholesale services; and cloud computing service that centralizes information management, hardware, network, and infrastructure in an off-premise location, hosted and managed by the company, as well as delivers a storage and data back-up assessment service as part of its storage offering, measuring growth, and duplication benchmarked against best practices. It markets and sells its business services through distribution partners, direct sales personnel, and inside sales representatives. Gawk Incorporated was incorporated in 2011 and is based in Los Angeles, California.

Full GAWK Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GAWK vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GAWK vs SCHDGAWK vs JEPIGAWK vs OGAWK vs KOGAWK vs MAINGAWK vs JNJGAWK vs ABBVGAWK vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.